Anterix Inc. (NASDAQ:ATEX) Shares Sold by Geode Capital Management LLC

Geode Capital Management LLC cut its stake in shares of Anterix Inc. (NASDAQ:ATEXFree Report) by 2.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 355,484 shares of the company’s stock after selling 8,259 shares during the period. Geode Capital Management LLC owned approximately 1.91% of Anterix worth $13,391,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. FMR LLC increased its position in shares of Anterix by 76.4% during the third quarter. FMR LLC now owns 250,955 shares of the company’s stock valued at $9,451,000 after acquiring an additional 108,683 shares during the last quarter. Gabelli Funds LLC increased its position in shares of Anterix by 4.7% during the second quarter. Gabelli Funds LLC now owns 140,422 shares of the company’s stock valued at $5,559,000 after acquiring an additional 6,322 shares during the last quarter. Jane Street Group LLC increased its position in shares of Anterix by 78.2% during the third quarter. Jane Street Group LLC now owns 128,892 shares of the company’s stock valued at $4,854,000 after acquiring an additional 56,559 shares during the last quarter. Marshall Wace LLP grew its holdings in shares of Anterix by 250.2% in the second quarter. Marshall Wace LLP now owns 58,652 shares of the company’s stock valued at $2,322,000 after purchasing an additional 41,905 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in shares of Anterix by 8.0% in the second quarter. Bank of New York Mellon Corp now owns 50,605 shares of the company’s stock valued at $2,003,000 after purchasing an additional 3,752 shares in the last quarter. 87.67% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Craig Hallum upgraded shares of Anterix to a “strong-buy” rating in a report on Wednesday, October 9th.

Get Our Latest Stock Report on ATEX

Anterix Stock Performance

Shares of ATEX stock opened at $30.51 on Tuesday. Anterix Inc. has a fifty-two week low of $29.12 and a fifty-two week high of $42.41. The stock has a market capitalization of $568.04 million, a P/E ratio of -15.10 and a beta of 0.85. The company has a 50 day moving average price of $33.05 and a 200 day moving average price of $35.59.

Insiders Place Their Bets

In other news, Director Leslie B. Daniels purchased 2,000 shares of the stock in a transaction on Wednesday, November 20th. The stock was bought at an average price of $32.75 per share, for a total transaction of $65,500.00. Following the acquisition, the director now directly owns 2,000 shares of the company’s stock, valued at approximately $65,500. The trade was a ∞ increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Mark Fleischhauer purchased 3,500 shares of the stock in a transaction on Thursday, December 5th. The shares were purchased at an average price of $34.19 per share, with a total value of $119,665.00. Following the acquisition, the director now directly owns 3,500 shares in the company, valued at $119,665. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. 45.61% of the stock is currently owned by company insiders.

Anterix Profile

(Free Report)

Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.

Featured Articles

Institutional Ownership by Quarter for Anterix (NASDAQ:ATEX)

Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.